nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—atopic dermatitis—allergic rhinitis	0.738	1	CtDrD
Pimecrolimus—CYP3A4—Flunisolide—allergic rhinitis	0.0245	0.192	CbGbCtD
Pimecrolimus—CYP3A4—Olopatadine—allergic rhinitis	0.023	0.18	CbGbCtD
Pimecrolimus—CYP3A4—Montelukast—allergic rhinitis	0.014	0.11	CbGbCtD
Pimecrolimus—CYP3A4—Loratadine—allergic rhinitis	0.014	0.11	CbGbCtD
Pimecrolimus—CYP3A4—Methylprednisolone—allergic rhinitis	0.0128	0.101	CbGbCtD
Pimecrolimus—CYP3A4—Triamcinolone—allergic rhinitis	0.00974	0.0764	CbGbCtD
Pimecrolimus—CYP3A4—Betamethasone—allergic rhinitis	0.00835	0.0656	CbGbCtD
Pimecrolimus—CYP3A4—Prednisolone—allergic rhinitis	0.00824	0.0647	CbGbCtD
Pimecrolimus—CYP3A4—Hydrocortisone—allergic rhinitis	0.00781	0.0613	CbGbCtD
Pimecrolimus—CYP3A4—Dexamethasone—allergic rhinitis	0.00486	0.0381	CbGbCtD
Pimecrolimus—MTOR—TSLP Signaling Pathway—TSLP—allergic rhinitis	0.00183	0.103	CbGpPWpGaD
Pimecrolimus—MTOR—respiratory system—allergic rhinitis	0.00131	0.109	CbGeAlD
Pimecrolimus—MTOR—eye—allergic rhinitis	0.0012	0.0999	CbGeAlD
Pimecrolimus—FKBP1A—respiratory system—allergic rhinitis	0.00118	0.0984	CbGeAlD
Pimecrolimus—MTOR—epithelium—allergic rhinitis	0.0011	0.0914	CbGeAlD
Pimecrolimus—FKBP1A—eye—allergic rhinitis	0.00108	0.0899	CbGeAlD
Pimecrolimus—MTOR—skin of body—allergic rhinitis	0.00104	0.0869	CbGeAlD
Pimecrolimus—FKBP1A—epithelium—allergic rhinitis	0.000986	0.0822	CbGeAlD
Pimecrolimus—FKBP1A—bronchus—allergic rhinitis	0.000971	0.0809	CbGeAlD
Pimecrolimus—FKBP1A—skin of body—allergic rhinitis	0.000938	0.0782	CbGeAlD
Pimecrolimus—FKBP1A—trachea—allergic rhinitis	0.000872	0.0727	CbGeAlD
Pimecrolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL4—allergic rhinitis	0.000853	0.0477	CbGpPWpGaD
Pimecrolimus—MTOR—Type II diabetes mellitus—ADIPOQ—allergic rhinitis	0.000815	0.0456	CbGpPWpGaD
Pimecrolimus—MTOR—CXCR3-mediated signaling events—CCL11—allergic rhinitis	0.000805	0.045	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—SMAD3—allergic rhinitis	0.000781	0.0436	CbGpPWpGaD
Pimecrolimus—MTOR—lung—allergic rhinitis	0.000696	0.0581	CbGeAlD
Pimecrolimus—MTOR—TSLP Signaling Pathway—CCL11—allergic rhinitis	0.000679	0.038	CbGpPWpGaD
Pimecrolimus—FKBP1A—lung—allergic rhinitis	0.000626	0.0522	CbGeAlD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFB1—allergic rhinitis	0.000575	0.0322	CbGpPWpGaD
Pimecrolimus—MTOR—IL4-mediated signaling events—CCL11—allergic rhinitis	0.000544	0.0304	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling—SMAD3—allergic rhinitis	0.000529	0.0296	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—SMAD3—allergic rhinitis	0.000514	0.0287	CbGpPWpGaD
Pimecrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—SMAD3—allergic rhinitis	0.000462	0.0258	CbGpPWpGaD
Pimecrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—SMAD3—allergic rhinitis	0.000417	0.0233	CbGpPWpGaD
Pimecrolimus—FKBP1A—ALK1 signaling events—TGFB1—allergic rhinitis	0.00039	0.0218	CbGpPWpGaD
Pimecrolimus—MTOR—IL4-mediated signaling events—IL5—allergic rhinitis	0.000367	0.0205	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000365	0.0204	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFB1—allergic rhinitis	0.000331	0.0185	CbGpPWpGaD
Pimecrolimus—MTOR—AMPK Signaling—ADIPOQ—allergic rhinitis	0.000327	0.0183	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—IL4—allergic rhinitis	0.000278	0.0155	CbGpPWpGaD
Pimecrolimus—MTOR—IL4-mediated signaling events—IL10—allergic rhinitis	0.000269	0.015	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—IL4—allergic rhinitis	0.000268	0.015	CbGpPWpGaD
Pimecrolimus—MTOR—Costimulation by the CD28 family—HLA-DQB1—allergic rhinitis	0.000264	0.0148	CbGpPWpGaD
Pimecrolimus—MTOR—IL4-mediated signaling events—IL4—allergic rhinitis	0.000261	0.0146	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—NFKB1—allergic rhinitis	0.000261	0.0146	CbGpPWpGaD
Pimecrolimus—MTOR—Regulation of Telomerase—SMAD3—allergic rhinitis	0.00024	0.0134	CbGpPWpGaD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—ICAM1—allergic rhinitis	0.000229	0.0128	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling—TGFB1—allergic rhinitis	0.000224	0.0125	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—ICAM1—allergic rhinitis	0.000221	0.0123	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—TGFB1—allergic rhinitis	0.000217	0.0122	CbGpPWpGaD
Pimecrolimus—MTOR—IL2 signaling events mediated by PI3K—NFKB1—allergic rhinitis	0.000199	0.0111	CbGpPWpGaD
Pimecrolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—allergic rhinitis	0.000196	0.0109	CbGpPWpGaD
Pimecrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFB1—allergic rhinitis	0.000177	0.00988	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—SMAD3—allergic rhinitis	0.00017	0.00949	CbGpPWpGaD
Pimecrolimus—MTOR—TSLP Signaling Pathway—NFKB1—allergic rhinitis	0.000164	0.00917	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—CD4—allergic rhinitis	0.000157	0.00876	CbGpPWpGaD
Pimecrolimus—Headache—Desloratadine—allergic rhinitis	0.000153	0.00146	CcSEcCtD
Pimecrolimus—Skin disorder—Loratadine—allergic rhinitis	0.000153	0.00146	CcSEcCtD
Pimecrolimus—Nausea—Cyproheptadine—allergic rhinitis	0.000149	0.00142	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Cetirizine—allergic rhinitis	0.000148	0.00141	CcSEcCtD
Pimecrolimus—Oedema—Cetirizine—allergic rhinitis	0.000148	0.00141	CcSEcCtD
Pimecrolimus—Pruritus—Olopatadine—allergic rhinitis	0.000147	0.00141	CcSEcCtD
Pimecrolimus—Infection—Cetirizine—allergic rhinitis	0.000147	0.0014	CcSEcCtD
Pimecrolimus—Oedema—Flunisolide—allergic rhinitis	0.000145	0.00139	CcSEcCtD
Pimecrolimus—Nervous system disorder—Cetirizine—allergic rhinitis	0.000145	0.00138	CcSEcCtD
Pimecrolimus—Nausea—Desloratadine—allergic rhinitis	0.000145	0.00138	CcSEcCtD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—NFKB1—allergic rhinitis	0.000145	0.00809	CbGpPWpGaD
Pimecrolimus—MTOR—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.000145	0.00809	CbGpPWpGaD
Pimecrolimus—Infection—Flunisolide—allergic rhinitis	0.000144	0.00138	CcSEcCtD
Pimecrolimus—Skin disorder—Cetirizine—allergic rhinitis	0.000144	0.00137	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Loratadine—allergic rhinitis	0.000143	0.00137	CcSEcCtD
Pimecrolimus—Diarrhoea—Olopatadine—allergic rhinitis	0.000143	0.00136	CcSEcCtD
Pimecrolimus—MTOR—Costimulation by the CD28 family—CD4—allergic rhinitis	0.000142	0.00792	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—MS4A2—allergic rhinitis	0.000142	0.00792	CbGpPWpGaD
Pimecrolimus—Paraesthesia—Loratadine—allergic rhinitis	0.000141	0.00135	CcSEcCtD
Pimecrolimus—Diarrhoea—Dimenhydrinate—allergic rhinitis	0.00014	0.00133	CcSEcCtD
Pimecrolimus—Diarrhoea—Diphenhydramine—allergic rhinitis	0.00014	0.00133	CcSEcCtD
Pimecrolimus—Angioedema—Montelukast—allergic rhinitis	0.000139	0.00132	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Loratadine—allergic rhinitis	0.000136	0.00129	CcSEcCtD
Pimecrolimus—MTOR—IL12-mediated signaling events—NFKB1—allergic rhinitis	0.000135	0.00755	CbGpPWpGaD
Pimecrolimus—Musculoskeletal discomfort—Cetirizine—allergic rhinitis	0.000135	0.00128	CcSEcCtD
Pimecrolimus—Constipation—Loratadine—allergic rhinitis	0.000134	0.00128	CcSEcCtD
Pimecrolimus—Pain—Loratadine—allergic rhinitis	0.000134	0.00128	CcSEcCtD
Pimecrolimus—Paraesthesia—Cetirizine—allergic rhinitis	0.000133	0.00127	CcSEcCtD
Pimecrolimus—Cough—Montelukast—allergic rhinitis	0.000133	0.00126	CcSEcCtD
Pimecrolimus—Vomiting—Olopatadine—allergic rhinitis	0.000133	0.00126	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Flunisolide—allergic rhinitis	0.000132	0.00126	CcSEcCtD
Pimecrolimus—Dyspnoea—Cetirizine—allergic rhinitis	0.000132	0.00126	CcSEcCtD
Pimecrolimus—Rash—Olopatadine—allergic rhinitis	0.000131	0.00125	CcSEcCtD
Pimecrolimus—Dermatitis—Olopatadine—allergic rhinitis	0.000131	0.00125	CcSEcCtD
Pimecrolimus—Headache—Olopatadine—allergic rhinitis	0.000131	0.00125	CcSEcCtD
Pimecrolimus—Vomiting—Diphenhydramine—allergic rhinitis	0.00013	0.00124	CcSEcCtD
Pimecrolimus—Vomiting—Dimenhydrinate—allergic rhinitis	0.00013	0.00124	CcSEcCtD
Pimecrolimus—Dyspnoea—Flunisolide—allergic rhinitis	0.00013	0.00124	CcSEcCtD
Pimecrolimus—Arthralgia—Montelukast—allergic rhinitis	0.000129	0.00123	CcSEcCtD
Pimecrolimus—Rash—Diphenhydramine—allergic rhinitis	0.000129	0.00123	CcSEcCtD
Pimecrolimus—Rash—Dimenhydrinate—allergic rhinitis	0.000129	0.00123	CcSEcCtD
Pimecrolimus—Dermatitis—Dimenhydrinate—allergic rhinitis	0.000129	0.00123	CcSEcCtD
Pimecrolimus—Dermatitis—Diphenhydramine—allergic rhinitis	0.000129	0.00123	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Loratadine—allergic rhinitis	0.000128	0.00123	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Montelukast—allergic rhinitis	0.000128	0.00122	CcSEcCtD
Pimecrolimus—Headache—Diphenhydramine—allergic rhinitis	0.000128	0.00122	CcSEcCtD
Pimecrolimus—Headache—Dimenhydrinate—allergic rhinitis	0.000128	0.00122	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.000128	0.00122	CcSEcCtD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	0.000127	0.00708	CbGpPWpGaD
Pimecrolimus—Constipation—Cetirizine—allergic rhinitis	0.000126	0.00121	CcSEcCtD
Pimecrolimus—Pain—Cetirizine—allergic rhinitis	0.000126	0.00121	CcSEcCtD
Pimecrolimus—Abdominal pain upper—Hydrocortisone—allergic rhinitis	0.000124	0.00119	CcSEcCtD
Pimecrolimus—Constipation—Flunisolide—allergic rhinitis	0.000124	0.00119	CcSEcCtD
Pimecrolimus—Pain—Flunisolide—allergic rhinitis	0.000124	0.00119	CcSEcCtD
Pimecrolimus—Body temperature increased—Loratadine—allergic rhinitis	0.000124	0.00118	CcSEcCtD
Pimecrolimus—Abdominal pain—Loratadine—allergic rhinitis	0.000124	0.00118	CcSEcCtD
Pimecrolimus—Oedema—Montelukast—allergic rhinitis	0.000124	0.00118	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Montelukast—allergic rhinitis	0.000124	0.00118	CcSEcCtD
Pimecrolimus—Nausea—Olopatadine—allergic rhinitis	0.000124	0.00118	CcSEcCtD
Pimecrolimus—Infection—Montelukast—allergic rhinitis	0.000123	0.00117	CcSEcCtD
Pimecrolimus—MTOR—Regulation of Telomerase—NFKB1—allergic rhinitis	0.000122	0.00683	CbGpPWpGaD
Pimecrolimus—Nervous system disorder—Montelukast—allergic rhinitis	0.000122	0.00116	CcSEcCtD
Pimecrolimus—Nausea—Dimenhydrinate—allergic rhinitis	0.000121	0.00116	CcSEcCtD
Pimecrolimus—Nausea—Diphenhydramine—allergic rhinitis	0.000121	0.00116	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Cetirizine—allergic rhinitis	0.000121	0.00115	CcSEcCtD
Pimecrolimus—MTOR—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.000121	0.00674	CbGpPWpGaD
Pimecrolimus—Skin disorder—Montelukast—allergic rhinitis	0.00012	0.00115	CcSEcCtD
Pimecrolimus—MTOR—CXCR4-mediated signaling events—CD4—allergic rhinitis	0.00012	0.00669	CbGpPWpGaD
Pimecrolimus—Gastrointestinal pain—Flunisolide—allergic rhinitis	0.000119	0.00113	CcSEcCtD
Pimecrolimus—Urticaria—Cetirizine—allergic rhinitis	0.000117	0.00112	CcSEcCtD
Pimecrolimus—Abdominal pain—Cetirizine—allergic rhinitis	0.000117	0.00111	CcSEcCtD
Pimecrolimus—Body temperature increased—Cetirizine—allergic rhinitis	0.000117	0.00111	CcSEcCtD
Pimecrolimus—FKBP1A—Spinal Cord Injury—TGFB1—allergic rhinitis	0.000116	0.00651	CbGpPWpGaD
Pimecrolimus—Breast disorder—Methylprednisolone—allergic rhinitis	0.000116	0.0011	CcSEcCtD
Pimecrolimus—Urticaria—Flunisolide—allergic rhinitis	0.000115	0.0011	CcSEcCtD
Pimecrolimus—Body temperature increased—Flunisolide—allergic rhinitis	0.000115	0.0011	CcSEcCtD
Pimecrolimus—Abdominal pain—Flunisolide—allergic rhinitis	0.000115	0.0011	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Montelukast—allergic rhinitis	0.000113	0.00108	CcSEcCtD
Pimecrolimus—MTOR—Leptin signaling pathway—NFKB1—allergic rhinitis	0.000113	0.00631	CbGpPWpGaD
Pimecrolimus—Paraesthesia—Montelukast—allergic rhinitis	0.000111	0.00106	CcSEcCtD
Pimecrolimus—Asthma—Triamcinolone—allergic rhinitis	0.000111	0.00106	CcSEcCtD
Pimecrolimus—Influenza—Triamcinolone—allergic rhinitis	0.000111	0.00106	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Hydrocortisone—allergic rhinitis	0.000109	0.00104	CcSEcCtD
Pimecrolimus—Hypersensitivity—Cetirizine—allergic rhinitis	0.000109	0.00104	CcSEcCtD
Pimecrolimus—Diarrhoea—Loratadine—allergic rhinitis	0.000108	0.00103	CcSEcCtD
Pimecrolimus—Hypersensitivity—Flunisolide—allergic rhinitis	0.000107	0.00102	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000107	0.00102	CcSEcCtD
Pimecrolimus—Bronchitis—Triamcinolone—allergic rhinitis	0.000107	0.00102	CcSEcCtD
Pimecrolimus—Pain—Montelukast—allergic rhinitis	0.000106	0.00101	CcSEcCtD
Pimecrolimus—Infestation NOS—Hydrocortisone—allergic rhinitis	0.000105	0.001	CcSEcCtD
Pimecrolimus—Infestation—Hydrocortisone—allergic rhinitis	0.000105	0.001	CcSEcCtD
Pimecrolimus—Pruritus—Cetirizine—allergic rhinitis	0.000105	0.000998	CcSEcCtD
Pimecrolimus—Conjunctivitis—Prednisolone—allergic rhinitis	0.000104	0.000996	CcSEcCtD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	0.000103	0.00577	CbGpPWpGaD
Pimecrolimus—Upper respiratory tract infection—Triamcinolone—allergic rhinitis	0.000103	0.000983	CcSEcCtD
Pimecrolimus—Pruritus—Flunisolide—allergic rhinitis	0.000103	0.000981	CcSEcCtD
Pimecrolimus—MTOR—Regulation of Telomerase—TGFB1—allergic rhinitis	0.000102	0.00569	CbGpPWpGaD
Pimecrolimus—Gastrointestinal pain—Montelukast—allergic rhinitis	0.000101	0.000967	CcSEcCtD
Pimecrolimus—Diarrhoea—Cetirizine—allergic rhinitis	0.000101	0.000965	CcSEcCtD
Pimecrolimus—Vomiting—Loratadine—allergic rhinitis	9.99e-05	0.000953	CcSEcCtD
Pimecrolimus—Diarrhoea—Flunisolide—allergic rhinitis	9.95e-05	0.000949	CcSEcCtD
Pimecrolimus—Rash—Loratadine—allergic rhinitis	9.91e-05	0.000945	CcSEcCtD
Pimecrolimus—Dermatitis—Loratadine—allergic rhinitis	9.9e-05	0.000944	CcSEcCtD
Pimecrolimus—Infestation—Methylprednisolone—allergic rhinitis	9.86e-05	0.000941	CcSEcCtD
Pimecrolimus—Infestation NOS—Methylprednisolone—allergic rhinitis	9.86e-05	0.000941	CcSEcCtD
Pimecrolimus—Urticaria—Montelukast—allergic rhinitis	9.85e-05	0.000939	CcSEcCtD
Pimecrolimus—Headache—Loratadine—allergic rhinitis	9.84e-05	0.000939	CcSEcCtD
Pimecrolimus—Body temperature increased—Montelukast—allergic rhinitis	9.8e-05	0.000935	CcSEcCtD
Pimecrolimus—Abdominal pain—Montelukast—allergic rhinitis	9.8e-05	0.000935	CcSEcCtD
Pimecrolimus—Conjunctivitis—Triamcinolone—allergic rhinitis	9.61e-05	0.000916	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	9.5e-05	0.00531	CbGpPWpGaD
Pimecrolimus—Vomiting—Cetirizine—allergic rhinitis	9.4e-05	0.000897	CcSEcCtD
Pimecrolimus—Nausea—Loratadine—allergic rhinitis	9.33e-05	0.00089	CcSEcCtD
Pimecrolimus—Epistaxis—Triamcinolone—allergic rhinitis	9.32e-05	0.000889	CcSEcCtD
Pimecrolimus—Rash—Cetirizine—allergic rhinitis	9.32e-05	0.000889	CcSEcCtD
Pimecrolimus—Dermatitis—Cetirizine—allergic rhinitis	9.31e-05	0.000888	CcSEcCtD
Pimecrolimus—Headache—Cetirizine—allergic rhinitis	9.26e-05	0.000883	CcSEcCtD
Pimecrolimus—Vomiting—Flunisolide—allergic rhinitis	9.24e-05	0.000881	CcSEcCtD
Pimecrolimus—Rash—Flunisolide—allergic rhinitis	9.17e-05	0.000874	CcSEcCtD
Pimecrolimus—Dermatitis—Flunisolide—allergic rhinitis	9.16e-05	0.000873	CcSEcCtD
Pimecrolimus—Hypersensitivity—Montelukast—allergic rhinitis	9.13e-05	0.000871	CcSEcCtD
Pimecrolimus—Headache—Flunisolide—allergic rhinitis	9.11e-05	0.000869	CcSEcCtD
Pimecrolimus—Rhinitis—Triamcinolone—allergic rhinitis	8.9e-05	0.000848	CcSEcCtD
Pimecrolimus—Rhinitis—Methylprednisolone—allergic rhinitis	8.88e-05	0.000846	CcSEcCtD
Pimecrolimus—Pharyngitis—Triamcinolone—allergic rhinitis	8.81e-05	0.00084	CcSEcCtD
Pimecrolimus—Eye disorder—Hydrocortisone—allergic rhinitis	8.81e-05	0.00084	CcSEcCtD
Pimecrolimus—Nausea—Cetirizine—allergic rhinitis	8.78e-05	0.000838	CcSEcCtD
Pimecrolimus—Pruritus—Montelukast—allergic rhinitis	8.77e-05	0.000837	CcSEcCtD
Pimecrolimus—Conjunctivitis—Dexamethasone—allergic rhinitis	8.72e-05	0.000831	CcSEcCtD
Pimecrolimus—Conjunctivitis—Betamethasone—allergic rhinitis	8.72e-05	0.000831	CcSEcCtD
Pimecrolimus—Nausea—Flunisolide—allergic rhinitis	8.63e-05	0.000824	CcSEcCtD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	8.59e-05	0.0048	CbGpPWpGaD
Pimecrolimus—Immune system disorder—Hydrocortisone—allergic rhinitis	8.51e-05	0.000812	CcSEcCtD
Pimecrolimus—Diarrhoea—Montelukast—allergic rhinitis	8.48e-05	0.000809	CcSEcCtD
Pimecrolimus—Erythema—Prednisolone—allergic rhinitis	8.4e-05	0.000801	CcSEcCtD
Pimecrolimus—Eye disorder—Methylprednisolone—allergic rhinitis	8.27e-05	0.000789	CcSEcCtD
Pimecrolimus—MTOR—Immune System—MS4A2—allergic rhinitis	8.25e-05	0.00462	CbGpPWpGaD
Pimecrolimus—Malnutrition—Hydrocortisone—allergic rhinitis	8.2e-05	0.000782	CcSEcCtD
Pimecrolimus—Erythema—Hydrocortisone—allergic rhinitis	8.2e-05	0.000782	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—PTGDR2—allergic rhinitis	8.07e-05	0.00451	CbGpPWpGaD
Pimecrolimus—Immune system disorder—Methylprednisolone—allergic rhinitis	8e-05	0.000763	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Methylprednisolone—allergic rhinitis	7.98e-05	0.000761	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	7.92e-05	0.00443	CbGpPWpGaD
Pimecrolimus—Vomiting—Montelukast—allergic rhinitis	7.88e-05	0.000752	CcSEcCtD
Pimecrolimus—Rash—Montelukast—allergic rhinitis	7.82e-05	0.000746	CcSEcCtD
Pimecrolimus—Dermatitis—Montelukast—allergic rhinitis	7.81e-05	0.000745	CcSEcCtD
Pimecrolimus—Headache—Montelukast—allergic rhinitis	7.77e-05	0.000741	CcSEcCtD
Pimecrolimus—Erythema—Triamcinolone—allergic rhinitis	7.72e-05	0.000737	CcSEcCtD
Pimecrolimus—Erythema—Methylprednisolone—allergic rhinitis	7.71e-05	0.000735	CcSEcCtD
Pimecrolimus—Malnutrition—Methylprednisolone—allergic rhinitis	7.71e-05	0.000735	CcSEcCtD
Pimecrolimus—Angioedema—Prednisolone—allergic rhinitis	7.67e-05	0.000732	CcSEcCtD
Pimecrolimus—Eye disorder—Dexamethasone—allergic rhinitis	7.52e-05	0.000718	CcSEcCtD
Pimecrolimus—Eye disorder—Betamethasone—allergic rhinitis	7.52e-05	0.000718	CcSEcCtD
Pimecrolimus—Angioedema—Hydrocortisone—allergic rhinitis	7.5e-05	0.000715	CcSEcCtD
Pimecrolimus—Back pain—Triamcinolone—allergic rhinitis	7.47e-05	0.000713	CcSEcCtD
Pimecrolimus—Nausea—Montelukast—allergic rhinitis	7.36e-05	0.000702	CcSEcCtD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-G—allergic rhinitis	7.35e-05	0.00411	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—allergic rhinitis	7.18e-05	0.00402	CbGpPWpGaD
Pimecrolimus—Angioedema—Triamcinolone—allergic rhinitis	7.06e-05	0.000673	CcSEcCtD
Pimecrolimus—Angioedema—Methylprednisolone—allergic rhinitis	7.04e-05	0.000672	CcSEcCtD
Pimecrolimus—Erythema—Betamethasone—allergic rhinitis	7.01e-05	0.000668	CcSEcCtD
Pimecrolimus—Erythema—Dexamethasone—allergic rhinitis	7.01e-05	0.000668	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	6.94e-05	0.000661	CcSEcCtD
Pimecrolimus—Oedema—Prednisolone—allergic rhinitis	6.85e-05	0.000654	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Prednisolone—allergic rhinitis	6.85e-05	0.000654	CcSEcCtD
Pimecrolimus—Cough—Triamcinolone—allergic rhinitis	6.74e-05	0.000643	CcSEcCtD
Pimecrolimus—MTOR—BDNF signaling pathway—NFKB1—allergic rhinitis	6.7e-05	0.00375	CbGpPWpGaD
Pimecrolimus—Oedema—Hydrocortisone—allergic rhinitis	6.69e-05	0.000639	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Hydrocortisone—allergic rhinitis	6.69e-05	0.000639	CcSEcCtD
Pimecrolimus—Infection—Hydrocortisone—allergic rhinitis	6.65e-05	0.000634	CcSEcCtD
Pimecrolimus—Nervous system disorder—Hydrocortisone—allergic rhinitis	6.57e-05	0.000626	CcSEcCtD
Pimecrolimus—Arthralgia—Methylprednisolone—allergic rhinitis	6.56e-05	0.000626	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	6.52e-05	0.000621	CcSEcCtD
Pimecrolimus—Skin disorder—Hydrocortisone—allergic rhinitis	6.5e-05	0.00062	CcSEcCtD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	6.45e-05	0.00361	CbGpPWpGaD
Pimecrolimus—Angioedema—Dexamethasone—allergic rhinitis	6.4e-05	0.000611	CcSEcCtD
Pimecrolimus—Angioedema—Betamethasone—allergic rhinitis	6.4e-05	0.000611	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—CYSLTR1—allergic rhinitis	6.33e-05	0.00354	CbGpPWpGaD
Pimecrolimus—Anaphylactic shock—Triamcinolone—allergic rhinitis	6.3e-05	0.000601	CcSEcCtD
Pimecrolimus—Oedema—Triamcinolone—allergic rhinitis	6.3e-05	0.000601	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Methylprednisolone—allergic rhinitis	6.29e-05	0.0006	CcSEcCtD
Pimecrolimus—Infection—Triamcinolone—allergic rhinitis	6.26e-05	0.000597	CcSEcCtD
Pimecrolimus—Infection—Methylprednisolone—allergic rhinitis	6.25e-05	0.000596	CcSEcCtD
Pimecrolimus—Nervous system disorder—Methylprednisolone—allergic rhinitis	6.17e-05	0.000588	CcSEcCtD
Pimecrolimus—Paraesthesia—Prednisolone—allergic rhinitis	6.16e-05	0.000587	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—CCL11—allergic rhinitis	6.11e-05	0.00342	CbGpPWpGaD
Pimecrolimus—Skin disorder—Methylprednisolone—allergic rhinitis	6.11e-05	0.000583	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	6.1e-05	0.000582	CcSEcCtD
Pimecrolimus—Paraesthesia—Hydrocortisone—allergic rhinitis	6.01e-05	0.000573	CcSEcCtD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	5.95e-05	0.00333	CbGpPWpGaD
Pimecrolimus—Pain—Prednisolone—allergic rhinitis	5.86e-05	0.000559	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	5.78e-05	0.000551	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	5.74e-05	0.000548	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	5.73e-05	0.000547	CcSEcCtD
Pimecrolimus—Pain—Hydrocortisone—allergic rhinitis	5.72e-05	0.000546	CcSEcCtD
Pimecrolimus—Oedema—Dexamethasone—allergic rhinitis	5.72e-05	0.000546	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Dexamethasone—allergic rhinitis	5.72e-05	0.000546	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Betamethasone—allergic rhinitis	5.72e-05	0.000546	CcSEcCtD
Pimecrolimus—Oedema—Betamethasone—allergic rhinitis	5.72e-05	0.000546	CcSEcCtD
Pimecrolimus—Infection—Dexamethasone—allergic rhinitis	5.68e-05	0.000542	CcSEcCtD
Pimecrolimus—Infection—Betamethasone—allergic rhinitis	5.68e-05	0.000542	CcSEcCtD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	5.68e-05	0.00318	CbGpPWpGaD
Pimecrolimus—Paraesthesia—Triamcinolone—allergic rhinitis	5.66e-05	0.00054	CcSEcCtD
Pimecrolimus—Paraesthesia—Methylprednisolone—allergic rhinitis	5.65e-05	0.000539	CcSEcCtD
Pimecrolimus—Dyspnoea—Triamcinolone—allergic rhinitis	5.62e-05	0.000536	CcSEcCtD
Pimecrolimus—Nervous system disorder—Dexamethasone—allergic rhinitis	5.61e-05	0.000535	CcSEcCtD
Pimecrolimus—Nervous system disorder—Betamethasone—allergic rhinitis	5.61e-05	0.000535	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	5.47e-05	0.000522	CcSEcCtD
Pimecrolimus—Urticaria—Prednisolone—allergic rhinitis	5.45e-05	0.000519	CcSEcCtD
Pimecrolimus—Pain—Triamcinolone—allergic rhinitis	5.39e-05	0.000514	CcSEcCtD
Pimecrolimus—Urticaria—Hydrocortisone—allergic rhinitis	5.32e-05	0.000507	CcSEcCtD
Pimecrolimus—Body temperature increased—Hydrocortisone—allergic rhinitis	5.29e-05	0.000505	CcSEcCtD
Pimecrolimus—Abdominal pain—Hydrocortisone—allergic rhinitis	5.29e-05	0.000505	CcSEcCtD
Pimecrolimus—MTOR—B Cell Activation—NFKB1—allergic rhinitis	5.26e-05	0.00294	CbGpPWpGaD
Pimecrolimus—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	5.21e-05	0.000497	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	5.21e-05	0.000497	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	5.14e-05	0.000491	CcSEcCtD
Pimecrolimus—Paraesthesia—Dexamethasone—allergic rhinitis	5.14e-05	0.00049	CcSEcCtD
Pimecrolimus—Paraesthesia—Betamethasone—allergic rhinitis	5.14e-05	0.00049	CcSEcCtD
Pimecrolimus—Hypersensitivity—Prednisolone—allergic rhinitis	5.05e-05	0.000482	CcSEcCtD
Pimecrolimus—Urticaria—Triamcinolone—allergic rhinitis	5.01e-05	0.000478	CcSEcCtD
Pimecrolimus—Urticaria—Methylprednisolone—allergic rhinitis	5e-05	0.000477	CcSEcCtD
Pimecrolimus—Body temperature increased—Triamcinolone—allergic rhinitis	4.98e-05	0.000475	CcSEcCtD
Pimecrolimus—Abdominal pain—Methylprednisolone—allergic rhinitis	4.97e-05	0.000474	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	4.94e-05	0.000471	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Betamethasone—allergic rhinitis	4.94e-05	0.000471	CcSEcCtD
Pimecrolimus—Hypersensitivity—Hydrocortisone—allergic rhinitis	4.93e-05	0.00047	CcSEcCtD
Pimecrolimus—Pain—Betamethasone—allergic rhinitis	4.89e-05	0.000466	CcSEcCtD
Pimecrolimus—Pain—Dexamethasone—allergic rhinitis	4.89e-05	0.000466	CcSEcCtD
Pimecrolimus—Pruritus—Hydrocortisone—allergic rhinitis	4.74e-05	0.000452	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Dexamethasone—allergic rhinitis	4.68e-05	0.000446	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Betamethasone—allergic rhinitis	4.68e-05	0.000446	CcSEcCtD
Pimecrolimus—Hypersensitivity—Triamcinolone—allergic rhinitis	4.64e-05	0.000443	CcSEcCtD
Pimecrolimus—Hypersensitivity—Methylprednisolone—allergic rhinitis	4.63e-05	0.000442	CcSEcCtD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-DQB1—allergic rhinitis	4.59e-05	0.00256	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Hydrocortisone—allergic rhinitis	4.58e-05	0.000437	CcSEcCtD
Pimecrolimus—Urticaria—Dexamethasone—allergic rhinitis	4.54e-05	0.000433	CcSEcCtD
Pimecrolimus—Urticaria—Betamethasone—allergic rhinitis	4.54e-05	0.000433	CcSEcCtD
Pimecrolimus—MTOR—Signaling Pathways—PTGDR2—allergic rhinitis	4.54e-05	0.00254	CbGpPWpGaD
Pimecrolimus—Body temperature increased—Betamethasone—allergic rhinitis	4.52e-05	0.000431	CcSEcCtD
Pimecrolimus—Body temperature increased—Dexamethasone—allergic rhinitis	4.52e-05	0.000431	CcSEcCtD
Pimecrolimus—Abdominal pain—Dexamethasone—allergic rhinitis	4.52e-05	0.000431	CcSEcCtD
Pimecrolimus—Abdominal pain—Betamethasone—allergic rhinitis	4.52e-05	0.000431	CcSEcCtD
Pimecrolimus—Pruritus—Triamcinolone—allergic rhinitis	4.46e-05	0.000425	CcSEcCtD
Pimecrolimus—MTOR—Immune System—HLA-G—allergic rhinitis	4.46e-05	0.00249	CbGpPWpGaD
Pimecrolimus—Pruritus—Methylprednisolone—allergic rhinitis	4.45e-05	0.000424	CcSEcCtD
Pimecrolimus—FKBP1A—Signaling Pathways—TAC1—allergic rhinitis	4.44e-05	0.00248	CbGpPWpGaD
Pimecrolimus—Rash—Prednisolone—allergic rhinitis	4.32e-05	0.000412	CcSEcCtD
Pimecrolimus—Dermatitis—Prednisolone—allergic rhinitis	4.32e-05	0.000412	CcSEcCtD
Pimecrolimus—Diarrhoea—Methylprednisolone—allergic rhinitis	4.3e-05	0.00041	CcSEcCtD
Pimecrolimus—Headache—Prednisolone—allergic rhinitis	4.29e-05	0.00041	CcSEcCtD
Pimecrolimus—Vomiting—Hydrocortisone—allergic rhinitis	4.26e-05	0.000406	CcSEcCtD
Pimecrolimus—Rash—Hydrocortisone—allergic rhinitis	4.22e-05	0.000403	CcSEcCtD
Pimecrolimus—Dermatitis—Hydrocortisone—allergic rhinitis	4.22e-05	0.000402	CcSEcCtD
Pimecrolimus—Headache—Hydrocortisone—allergic rhinitis	4.19e-05	0.0004	CcSEcCtD
Pimecrolimus—FKBP1A—Disease—SMAD3—allergic rhinitis	4.15e-05	0.00232	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL5—allergic rhinitis	4.13e-05	0.00231	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—NFKB1—allergic rhinitis	4.12e-05	0.00231	CbGpPWpGaD
Pimecrolimus—Nausea—Prednisolone—allergic rhinitis	4.07e-05	0.000388	CcSEcCtD
Pimecrolimus—Pruritus—Betamethasone—allergic rhinitis	4.05e-05	0.000386	CcSEcCtD
Pimecrolimus—Pruritus—Dexamethasone—allergic rhinitis	4.05e-05	0.000386	CcSEcCtD
Pimecrolimus—Vomiting—Triamcinolone—allergic rhinitis	4.01e-05	0.000382	CcSEcCtD
Pimecrolimus—Vomiting—Methylprednisolone—allergic rhinitis	4e-05	0.000381	CcSEcCtD
Pimecrolimus—Nausea—Hydrocortisone—allergic rhinitis	3.98e-05	0.000379	CcSEcCtD
Pimecrolimus—Rash—Triamcinolone—allergic rhinitis	3.97e-05	0.000379	CcSEcCtD
Pimecrolimus—Dermatitis—Triamcinolone—allergic rhinitis	3.97e-05	0.000379	CcSEcCtD
Pimecrolimus—Rash—Methylprednisolone—allergic rhinitis	3.97e-05	0.000378	CcSEcCtD
Pimecrolimus—Dermatitis—Methylprednisolone—allergic rhinitis	3.96e-05	0.000378	CcSEcCtD
Pimecrolimus—Headache—Triamcinolone—allergic rhinitis	3.95e-05	0.000377	CcSEcCtD
Pimecrolimus—Headache—Methylprednisolone—allergic rhinitis	3.94e-05	0.000376	CcSEcCtD
Pimecrolimus—Diarrhoea—Betamethasone—allergic rhinitis	3.91e-05	0.000373	CcSEcCtD
Pimecrolimus—Diarrhoea—Dexamethasone—allergic rhinitis	3.91e-05	0.000373	CcSEcCtD
Pimecrolimus—MTOR—Signaling by NGF—NFKB1—allergic rhinitis	3.87e-05	0.00216	CbGpPWpGaD
Pimecrolimus—Nausea—Triamcinolone—allergic rhinitis	3.74e-05	0.000357	CcSEcCtD
Pimecrolimus—Nausea—Methylprednisolone—allergic rhinitis	3.74e-05	0.000356	CcSEcCtD
Pimecrolimus—Vomiting—Betamethasone—allergic rhinitis	3.64e-05	0.000347	CcSEcCtD
Pimecrolimus—Vomiting—Dexamethasone—allergic rhinitis	3.64e-05	0.000347	CcSEcCtD
Pimecrolimus—Rash—Betamethasone—allergic rhinitis	3.61e-05	0.000344	CcSEcCtD
Pimecrolimus—Rash—Dexamethasone—allergic rhinitis	3.61e-05	0.000344	CcSEcCtD
Pimecrolimus—Dermatitis—Dexamethasone—allergic rhinitis	3.6e-05	0.000344	CcSEcCtD
Pimecrolimus—Dermatitis—Betamethasone—allergic rhinitis	3.6e-05	0.000344	CcSEcCtD
Pimecrolimus—MTOR—Immune System—IL5—allergic rhinitis	3.59e-05	0.00201	CbGpPWpGaD
Pimecrolimus—Headache—Dexamethasone—allergic rhinitis	3.58e-05	0.000342	CcSEcCtD
Pimecrolimus—Headache—Betamethasone—allergic rhinitis	3.58e-05	0.000342	CcSEcCtD
Pimecrolimus—MTOR—Signaling Pathways—CYSLTR1—allergic rhinitis	3.56e-05	0.00199	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL11—allergic rhinitis	3.44e-05	0.00192	CbGpPWpGaD
Pimecrolimus—Nausea—Dexamethasone—allergic rhinitis	3.4e-05	0.000324	CcSEcCtD
Pimecrolimus—Nausea—Betamethasone—allergic rhinitis	3.4e-05	0.000324	CcSEcCtD
Pimecrolimus—MTOR—Adaptive Immune System—ICAM1—allergic rhinitis	3.35e-05	0.00187	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SMAD3—allergic rhinitis	2.91e-05	0.00163	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DQB1—allergic rhinitis	2.78e-05	0.00156	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CD4—allergic rhinitis	2.56e-05	0.00143	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TAC1—allergic rhinitis	2.5e-05	0.0014	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD4—allergic rhinitis	2.46e-05	0.00138	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CD4—allergic rhinitis	2.45e-05	0.00137	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SMAD3—allergic rhinitis	2.33e-05	0.00131	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL5—allergic rhinitis	2.32e-05	0.0013	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—NFKB1—allergic rhinitis	2.21e-05	0.00123	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—NFKB1—allergic rhinitis	2.12e-05	0.00119	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ICAM1—allergic rhinitis	2.03e-05	0.00114	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TGFB1—allergic rhinitis	1.76e-05	0.000983	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SMAD3—allergic rhinitis	1.63e-05	0.000914	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD4—allergic rhinitis	1.49e-05	0.000834	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NFKB1—allergic rhinitis	1.48e-05	0.000826	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CD4—allergic rhinitis	1.38e-05	0.00077	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—NFKB1—allergic rhinitis	1.29e-05	0.000719	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TGFB1—allergic rhinitis	1.23e-05	0.000688	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TGFB1—allergic rhinitis	9.89e-06	0.000553	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NFKB1—allergic rhinitis	8.31e-06	0.000465	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TGFB1—allergic rhinitis	6.92e-06	0.000387	CbGpPWpGaD
